|...Company Profile||Board of Directors||Company History|
|Safe Harbour||Privacy Statement|
The company has chosen the emergency medical product sector as its market entry point for three reasons: (1) acute awareness of the potential for disease transmission makes infection control critically important to this sector; (2) acceptance and validation of 2H Technology efficiencies and performance in this rigidly controlled sector will facilitate acceptance of future products in other sectors; and (3) because hydrophobic/hydrophilic dual-filtered technology outperforms all current products on the market. The response to this strategy has resulted in the Company’s sharp increase in sales to the US Department of Defense (DOD).
The DOD endorsement, and escalating orders, provide an excellent platform for the next phase in the Company’s business development; entry into the acute respiratory care sector. Although the Company’s internationally patented dual-filtered technology (2H Technology) can be used in a wide range of medical and commercial applications, the Company has chosen to initially focus on sales in the Emergency Medical Services (EMS) segments, including fire department, law enforcement, ambulance, and medical air evacuation and then to expand into hospital based emergency room services. The funds currently being raised are necessary in order to facilitate marketing initiatives and produce an adequate level of inventory to accomplish the near-term objectives of growing sales in the EMS market, expanding the product line into the hospital market, establishing channels for the environmental mask, and accelerating the nanotechnology initiative.
Future 2H Technology products are in the stages of strategic planning and development. They include: (1) additional breathing circuit filters with filter media specifications and configurations modified to address specific applications in ventilator and anesthesia circuitry; (2) additional models of disposable and reusable BVM resuscitators, enhancing the Company’s ability to grow market share; (3) First Aid and Emergency Prep Kits featuring RespAide and customized for specific environments; (4) air filtration systems for semiconductor manufacturing and laboratory "clean rooms"; (5) and additional environmental and surgical facemasks.
1. “World Respiratory Therapy Care Product Markets,” MRIC Div., Frost & Sullivan, 1993, Mountain View, CA